Evidence map›Paper›PMID 36926633›Full record

ArticleFrontiers in aging neuroscience2023

Editorial: Early detection of neurodegenerative disorders using behavioral markers and new technologies: New methods and perspectives.

Valeria Manera, Erika Rovini, Peter Wais

Full text readEditorial
In one paragraph

Article in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Methods for Conjugating Antibodies with Quantum Dots.Molecules (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Neurodegeneration-related genes influencemicroPublication biology · 2024
    Article
  10. Article
  11. Delayed primacy recall performance predictsAlzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Valeria ManeraCoBTeK Lab, Department of Speech Therapy, Université Cote d'Azur, Nice, France.
Erika RoviniDepartment of Industrial Engineering, University of Florence, Florence, Italy.
Peter WaisDepartment of Neurology, Neuroscape and Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer's diseaseartificial intelligencebehavioral markersearly assessmentmild cognitive impairmentneurodegenerative diseasesnew technologies (ICT)Parkinson's disease (PD)

Identifiers

PMID36926633
PMCPMC10013194

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.